SCHEMBL6172290

SCHEMBL6172290

COc1ccc2nccc(CC3(C)NC(=O)N(c4ccc(SC(F)(F)F)cc4)C3=O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 16/20 0.45
ROCK2 O75116 1/20 0.39
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174389 0.89 IGF1R (0.42) IGF1RSMN1; SMN2
SCHEMBL6173427 0.86 IGF1R (0.45) IGF1R
SCHEMBL6175028 0.86 IGF1R (0.45) IGF1R
SCHEMBL6174899 0.86 IGF1R (0.45) IGF1RSMN1; SMN2
SCHEMBL6173786 0.85 IGF1R (0.50) IGF1RROCK2MTNR1AMTNR1B
SCHEMBL6173605 0.84 IGF1R (0.45) IGF1R
SCHEMBL6174285 0.83 IGF1R (0.46) IGF1R
Trifluoroacetic Acid SCHEMBL17558379 0.82 IGF1R (0.42) IGF1R
SCHEMBL6175587 0.82 IGF1R (0.45) IGF1R
SCHEMBL6171778 0.82 IGF1R (0.40) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed